The burden of seasonal and pandemic influenza in infants and children
- PMID: 23661234
- PMCID: PMC3930829
- DOI: 10.1007/s00431-013-2023-6
The burden of seasonal and pandemic influenza in infants and children
Abstract
The burden of influenza is unevenly distributed, with more severe outcomes in children aged <5 years than older children and adults. In spite of this, immunisation policies for young children are far from universal. This article provides an overview of the published evidence on the burden of influenza in children worldwide, with a particular interest in the impact of pandemic influenza in 2009-2010 (caused by the H1N1pdm09 virus). In an average season, up to 9.8 % of 0- to 14-year olds present with influenza, but incidence rates can be markedly higher in younger children. Children aged <5 years have greater rates of hospitalisation and complications than their older counterparts, particularly if the children have co-existing illnesses; historically, this age group have had higher mortality rates from the disease than other children, although during the 2009-2010 pandemic the median age of those who died of influenza was higher than in previous seasons. Admissions to hospital and emergency departments appear to have been more frequent in children with H1N1pdm09 infections than during previous seasonal epidemics, with pneumonia continuing to be a common complication in this setting. Outcomes in children hospitalised with severe disease also seem to have been worse for those infected with H1N1pdm09 viruses compared with seasonal viruses. Studies in children confirm that vaccination reduces the incidence of seasonal influenza and the associated burden, underlining the importance of targeting this group in national immunisation policies.
Conclusions: Children aged <5 years are especially vulnerable to influenza, particularly that caused by seasonal viruses, and vaccination in this group can be an effective strategy for reducing disease burden.
Figures
Similar articles
-
Influenza-associated hospitalisations in Finland from 1996 to 2010: unexpected age-specific burden during the influenza A(H1N1)pdm09 pandemic from 2009 to 2010.Euro Surveill. 2012 Sep 20;17(38):20276. Euro Surveill. 2012. PMID: 23040966
-
[Technical guidelines for seasonal influenza vaccination in China (2020-2021)].Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Oct 6;54(10):1035-1059. doi: 10.3760/cma.j.cn112150-20200911-01198. Zhonghua Yu Fang Yi Xue Za Zhi. 2020. PMID: 33131228 Chinese.
-
The relative clinical impact of 2009 pandemic influenza A (H1N1) in the community compared to seasonal influenza in the Netherlands was most marked among 5-14 year olds.Influenza Other Respir Viruses. 2011 Nov;5(6):e513-20. doi: 10.1111/j.1750-2659.2011.00260.x. Epub 2011 May 9. Influenza Other Respir Viruses. 2011. PMID: 21668666 Free PMC article.
-
Clinical and socioeconomic impact of pediatric seasonal and pandemic influenza.Hum Vaccin Immunother. 2012 Jan;8(1):17-20. doi: 10.4161/hv.8.1.18145. Epub 2012 Jan 1. Hum Vaccin Immunother. 2012. PMID: 22252002 Review.
-
Incidence of laboratory-confirmed influenza disease among infants under 6 months of age: a systematic review.BMJ Open. 2017 Sep 7;7(9):e016526. doi: 10.1136/bmjopen-2017-016526. BMJ Open. 2017. PMID: 28882916 Free PMC article. Review.
Cited by
-
Host susceptibility to severe influenza A virus infection.Crit Care. 2019 Sep 5;23(1):303. doi: 10.1186/s13054-019-2566-7. Crit Care. 2019. PMID: 31488196 Free PMC article. Review.
-
Investigating Different Mechanisms of Action in Combination Therapy for Influenza.Front Pharmacol. 2018 Oct 23;9:1207. doi: 10.3389/fphar.2018.01207. eCollection 2018. Front Pharmacol. 2018. PMID: 30405419 Free PMC article.
-
Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Children and Adolescents: A Systematic Review.Vaccines (Basel). 2021 Sep 29;9(10):1102. doi: 10.3390/vaccines9101102. Vaccines (Basel). 2021. PMID: 34696210 Free PMC article. Review.
-
COVID-19 breakthroughs: separating fact from fiction.FEBS J. 2020 Sep;287(17):3612-3632. doi: 10.1111/febs.15442. Epub 2020 Jul 5. FEBS J. 2020. PMID: 32500928 Free PMC article. Review.
-
One size does not fit all - Patterns of vulnerability and resilience in the COVID-19 pandemic and why heterogeneity of disease matters.Brain Behav Immun. 2020 Jul;87:1-3. doi: 10.1016/j.bbi.2020.03.016. Epub 2020 Mar 20. Brain Behav Immun. 2020. PMID: 32205119 Free PMC article. Review. No abstract available.
References
-
- Allison MA, Daley MF, Crane LA, Barrow J, Beaty BL, Allred N, Berman S, Kempe A. Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003–2004 season. J Pediatr. 2006;149(6):755–762. - PubMed
-
- Ambrose CS, Wu X, Knuf M, Wutzler P. The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies. Vaccine. 2012;30(5):886–892. - PubMed
-
- Ampofo K, Gesteland PH, Bender J, Mills M, Daly J, Samore M, Byington C, Pavia AT, Srivastava R. Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics. 2006;118(6):2409–2417. - PubMed
-
- Ampofo K, Herbener A, Blaschke AJ, Heyrend C, Poritz M, Korgenski K, Rolfs R, Jain S, Carvalho Mda G, Pimenta FC, Daly J, Mason EO, Byington CL, Pavia AT. Association of 2009 pandemic influenza A (H1N1) infection and increased hospitalization with parapneumonic empyema in children in Utah. Pediatr Infect Dis J. 2010;29(10):905–909. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical